Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation

References

• Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–6. doi:10.2105/AJPH.2007.131714.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–59. doi:10.1016/j.vaccine.2014.01.081.
   PubMed Web of Science ®Google Scholar
• Eskola J, Kilpi T. Public–private collaboration in vaccine research. Lancet. 2011;378(9789):385–86. doi:10.1016/S0140-6736(11)60690-9.
   PubMed Web of Science ®Google Scholar
• Dobson SRM, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. 2013;309(17):1793–802. doi:10.1001/jama.2013.1625.
   PubMed Web of Science ®Google Scholar
• Committee on conflict of interest in medical research, education, and practice, board on health sciences policy. Policies on conflict of interest: overview and evidence. Washington D.C.: National Academies Press; 2009. p. 62–96.
   Google Scholar
• Crowcroft NS, Rosella LC, Pakes BN. The ethics of sharing preliminary research findings during public health emergencies: a case study from the 2009 influenza pandemic. Euro surveillance: bull Europ sur les maladies transmissibles = Eur Commun Dis Bull. 2014;19:20831.
   PubMedGoogle Scholar
• Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen S-L, Hublin C, Julkunen I, Olsén P, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PloS One. 2012;7(3):e33536. doi:10.1371/journal.pone.0033536.
   PubMed Web of Science ®Google Scholar
• Lundh A, Barbateskovic M, Hrobjartsson A, Gotzsche PC. Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue – cohort study. PLoS Med. 2010;7(10):e1000354. doi:10.1371/journal.pmed.1000354.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Debalini MG, Rivetti A, Demicheli V. Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review. BMJ. 2009;338(feb122):b354–b354. doi:10.1136/bmj.b354.
   PubMedGoogle Scholar
• The Editors of The Lancet. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010;375(9713):445–445. doi:10.1016/S0140-6736(10)60175-4.
   PubMed Web of Science ®Google Scholar
• Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus [press release]; 2020. 18 May 2020.
   Google Scholar
• Petition: Give the Meningitis B vaccine to ALL children, not just newborn babies.
   Google Scholar
• NIH Clinical Trial. Shows Remdesivir Accelerates Recovery from Advanced COVID-19 [press release]; 2020. 29 April 2020.
   Google Scholar
• Chit A, Lee JKH, Shim M, Nguyen VH, Grootendorst P, Wu J, Van Exan R, Langley JM. Economic evaluation of vaccines in Canada: a systematic review. Hum Vaccin Immunother. 2016;12(5):1257–64. doi:10.1080/21645515.2015.1137405.
   PubMed Web of Science ®Google Scholar
• Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017;2:MR000033. doi:10.1002/14651858.MR000033.pub3.
   PubMed Web of Science ®Google Scholar
• Fickweiler W, Urbach E. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review. BMJ Open. 2017;7(9):e016408. doi:10.1136/bmjopen-2017-016408.
   PubMed Web of Science ®Google Scholar
• Elder K, Turner KA, Cosgrove L, Lexchin J, Shnier A, Moore A, Straus S, Thombs BD. 2020. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study. Can Med Assoc J (CMAJ). 192(23). E617-E625.
   Google Scholar
• George SL, Buyse M. Data fraud in clinical trials. Clin Investig (Lond). 2015;5(2):161–73. doi:10.4155/cli.14.116.
   PubMedGoogle Scholar
• Mello MM, Wood J, Burris S, Wagenaar AC, Ibrahim JK, Swanson JW. Critical opportunities for public health law: a call for action. A J Public Health (1971). 2013;103(11):1979–88. doi:10.2105/AJPH.2013.301281.
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada. Canadian human papillomavirus vaccine research priorities workshop: final report. Can Commun Dis Rep. 2006;32(S1):1–66.
   Google Scholar
• Mah CL, Deber RB, Guttmann A, McGeer A, Krahn M. Another look at the human papillomavirus vaccine experience in Canada. A J Public Health (1971). 2011;101(10):1850–57. doi:10.2105/AJPH.2011.300205.
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada. Government of Canada’s research response to COVID-19; 2020; Ottawa, Public Health Agency of Canada.
   Google Scholar
• National Insitutes of Health. Accelerating COVID-19. Therapeutic Interventions and Vaccines (ACTIV); 2020 [accessed 2020 Dec 16]. https://www.nih.gov/research-training/medical-research-initiatives/activ
   Google Scholar
• Dunn AG, Coiera E, Mandl KD, Bourgeois FT. Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Int Peer Rev. 2016;1(1):1. doi:10.1186/s41073-016-0006-7.
   PubMedGoogle Scholar